Lifetime Cost Effectiveness of Phenylketonuria Screening Na-tional Program in Iran
Background: Phenylketonuria (PKU) is an autosomal recessive disorder that screening and timely control of this disorder can prevent the adverse effects. Regarding the high prevalence of PKU in Iran, the PKU screening program was started in Iran in 2006. This study was conducted to determine the cos...
Enregistré dans:
Auteurs principaux: | Alireza Heidari, Mohammad Arab, Behzad Damari |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Tehran University of Medical Sciences
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d329c8e167cc4ad4ba25f7b96aa5bc6a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An Updated <i>PAH</i> Mutational Spectrum of Phenylketonuria in Mexican Patients Attending a Single Center: Biochemical, Clinical-Genotyping Correlations
par: Marcela Vela-Amieva, et autres
Publié: (2021) -
Evaluation of Nutritional Status and Growth in Phenylketonuria Patients in Mazandaran Province Iran
par: Eshraghi P, Abbaskhanian A, Bijani A, Hosseinzadeh S
Publié: (2011) -
Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
par: Reza Zamani, et autres
Publié: (2021) -
Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia
par: Valentina Rovelli, et autres
Publié: (2021) -
Italian national consensus statement on management and pharmacological treatment of phenylketonuria
par: Alberto Burlina, et autres
Publié: (2021)